Dr. Brian Ratzel, MD
What this data tells you about Dr. Ratzel
Dr. Brian Ratzel is an emergency medicine in Bartow, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ratzel performed 1,661 Medicare services across 1,468 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ratzel received a total of $37 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in emergency medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ratzel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Detection test by immunoassay with direct visual observation for influenza virus | 156 | $16 | $72 |
| Office visit, established patient (20-29 min) | 138 | $65 | $337 |
| Complete blood count (CBC) with differential | 100 | $8 | $40 |
| Office visit, established patient (30-39 min) | 90 | $99 | $1,200 |
| New patient office visit (30-44 min) | 88 | $73 | $337 |
| Automated urinalysis | 82 | $2 | $11 |
| Chest X-ray, 2 views | 71 | $22 | $120 |
| Basic metabolic blood panel | 62 | $8 | $44 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 61 | $41 | $41 |
| Anti-nausea injection (ondansetron/Zofran) | 60 | $0 | $1 |
| New patient office visit (45-59 min) | 57 | $129 | $1,200 |
| Electrocardiogram (EKG), 12-lead | 54 | $11 | $97 |
| Troponin (protein) analysis, quantitative | 51 | $12 | $1,500 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 46 | $1 | $4 |
| Ceftriaxone antibiotic injection | 44 | $0 | $64 |
| Injection, ketorolac tromethamine, per 15 mg | 39 | $0 | $15 |
| Injection of drug or substance into vein | 37 | $28 | $1,460 |
| Ct scan of abdomen and pelvis without contrast | 36 | $130 | $593 |
| Infusion into a vein for hydration, 31-60 minutes | 28 | $22 | $1,194 |
| Drug injection, under skin or into muscle | 28 | $10 | $61 |
| Amylase (enzyme) level | 27 | $6 | $39 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 27 | $90 | $92 |
| Injection of additional new drug or substance into vein | 23 | $12 | $1,460 |
| Comprehensive metabolic blood panel | 22 | $10 | $38 |
| Infusion into a vein for hydration, each additional hour | 22 | $10 | $1,210 |
| CT scan of head/brain, without contrast | 21 | $55 | $1,460 |
| Creatine kinase (cardiac enzyme) level, total | 21 | $6 | $34 |
| Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) | 19 | $7 | $36 |
| Blood creatinine level | 19 | $5 | $21 |
| Urea nitrogen level to assess kidney function, quantitative | 19 | $4 | $24 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 19 | $16 | $72 |
| Shoulder X-ray, 2+ views | 15 | $22 | $179 |
| Blood glucose (sugar) test performed by hand-held instrument | 15 | $3 | $12 |
| Coagulation function measurement, d-dimer; quantitative | 14 | $10 | $1,500 |
| Infusion, normal saline solution, 250 cc | 14 | $0 | $12 |
| CT scan of abdomen and pelvis with contrast | 13 | $204 | $917 |
| Blood gases measurement, with o2 saturation | 12 | $77 | $315 |
| Ct scan of upper spine without contrast | 11 | $90 | $1,855 |
Industry Payment Transparency
Open Payments through 2020 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2020)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2020 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ratzel is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ratzel experienced with detection test by immunoassay with direct visual observation for influenza virus?
Does Dr. Ratzel receive payments from pharmaceutical companies?
How do Dr. Ratzel's costs compare to other emergency medicines in Bartow?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology